Clinical Assessment of Bifluorid 10 vs Varnish Fluoride on The Exposed Hypersensitive Cervical Dentin in Adult Patient

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04485299
Collaborator
(none)
68
2
3

Study Details

Study Description

Brief Summary

Aim of the study will be conducted to compare the efficacy of bifluoride (NaF and CaF) versus conventional fluoride varnish (Sodium Flouride) in the management of hypersensitivity of exposed cervical area in adult patients over 2 month

Condition or Disease Intervention/Treatment Phase
  • Drug: Bifluorid 10 ,VOCO
  • Drug: Sodium Fluoride 5% Dental Varnish
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Quantitative Clinical Assessment of Bifluorid 10 Versus Varnish Fluoride on The Exposed Hypersensitive Cervical Dentin in Adult Patient: A Randomized Clinical Trial
Anticipated Study Start Date :
Oct 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Jan 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: bifluorid 10 varnish

Bifluorid 10 (NaF and CaF) lead to reduce the dentin hypersensitivity, the sodium fluoride (NaF) dissociates and releases F ions, that diffuse through the tubules and then precipitates as calcium fluoride as a consequence of the high of calcium content in saliva and dentinal fluid ,The calcium fluoride (CaF) present in the varnish composition diffuses into the tubules and block the canal with a semi-permanent protective layer.The calcium fluoride is added to block the dentin tubules mechanically, by the combination with the calcium fluoride resulted from the sodium fluoride reaction to the calcium of dentin.

Drug: Bifluorid 10 ,VOCO
NaF and CaF 10 %
Other Names:
  • Bifluorid 10
  • Active Comparator: sodium fluoride varnish

    Topical application of varnish fluoride (sodium fluoride NaF) effect on exposed dentine as a desensitizing agent, the varnish fluoride process is caused by the reaction between NaF and calcium ions resulting in calcium fluoride crystals being deposited on the openings of the dentinal tubules that decrease pain.

    Drug: Sodium Fluoride 5% Dental Varnish
    5% NaF
    Other Names:
  • conventional sodium fluoride varnish
  • Outcome Measures

    Primary Outcome Measures

    1. Dentin hypersensitivity [pre-intervention]

      measurement of dentin hypersensitivity by VAS scale

    2. Dentin hypersensitivity [2 min]

      measurement of dentin hypersensitivity by VAS scale

    3. Dentin hypersensitivity [1 week]

      measurement of dentin hypersensitivity by VAS scale

    4. Dentin hypersensitivity [4 weeks]

      measurement of dentin hypersensitivity by VAS scale

    5. Dentin hypersensitivity [8 weeks]

      measurement of dentin hypersensitivity by VAS scale

    Secondary Outcome Measures

    1. Dentinal tubule occlusion [Pre-intervention]

      Percentage of dentinal tubule occlusion measure by scanning electron microscope SEM

    2. Dentinal tubule occlusion [8 weeks]

      Percentage of dentinal tubule occlusion measure by scanning electron microscope SEM

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy patient with free medical history.

    • Age range 18-60 years old.

    • Good oral hygiene

    • Patients suffering from pain due to dentin hypersensitivity.

    • Patient with sound first molar .

    Exclusion Criteria:
    • Patients using desensitizing agents, receiving periodontal treatment or had received nonsurgical periodontal treatment in the last three months.

    • Patient wearing orthodontic appliance.

    • Patient with teeth having a painful condition involving the pulp and periapical region.

    • Patients who had allergy to materials will be used in the study.

    • Pregnancy.

    • Patient who does not consent to participation.

    • Patient who does not attend to the follow up.

    • A patient who has a carious first molar.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zaid Yousef Fakhry Al khateeb, Master's degree student - faculty of dentistry, Cairo University
    ClinicalTrials.gov Identifier:
    NCT04485299
    Other Study ID Numbers:
    • OPR 20/7/2020
    First Posted:
    Jul 24, 2020
    Last Update Posted:
    Jul 24, 2020
    Last Verified:
    Jul 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 24, 2020